Advertisement
Screener

Amgen Inc. (AMGN) Buildings and Improvements, Gross

2.3 / 5 stars · 55/120 Roast Me

Amgen Inc. Buildings and Improvements, Gross

Amgen Inc. (AMGN) had Buildings and Improvements, Gross of $4.20 billion as of 2022-12-31, per its 10-K filed 2023-02-09.

Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization

us-gaap:BuildingsAndImprovementsGross · last filed 2023-02-09

  • 2022-12-31: Buildings and Improvements, Gross $4.20B.
  • 2021-12-31: Buildings and Improvements, Gross $4.03B.
  • 2020-12-31: Buildings and Improvements, Gross $3.86B.
  • 2019-12-31: Buildings and Improvements, Gross $3.76B.
Period endBuildings and Improvements, Gross
2022-12-31$4.20B
10-K · filed 2023-02-09
2021-12-31$4.03B
10-K · filed 2023-02-09
2020-12-31$3.86B
10-K · filed 2022-02-16
2019-12-31$3.76B
10-K · filed 2021-02-09
2018-12-31$3.62B
10-K · filed 2020-02-12
2017-12-31$3.51B
10-K · filed 2019-02-13
2016-12-31$3.64B
10-K · filed 2018-02-13
2015-12-31$3.64B
10-K · filed 2017-02-14
2014-12-31$3.61B
8-K · filed 2016-10-31
2013-12-31$3.47B
10-K · filed 2015-02-19
2012-12-31$3.51B
10-K · filed 2014-02-24
2011-12-31$3.46B
10-K · filed 2013-02-27
2010-12-31$3.39B
10-K · filed 2012-02-29
2009-12-31$3.29B
10-K · filed 2011-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
GILEAD SCIENCES, INC. (GILD)United States$185.522B-48.37
Moderna, Inc. (MRNA)United States$77.819B-8.86
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
BIOGEN INC. (BIIB)United States$33.427B19.60
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31